The remainder of this review will focus on the IGFBP-3 receptor TMEM219 in human cancer by mainly providing the evidence to date regarding the IGFBP-3/TMEM219 system as an anti-tumor and anti-metastatic signaling in human cancer. This evidence concerns the gene IGFBP3 and cancer.